Digest
Network
Come funziona
Digest
/ Comunicato
calendar_today
11/01/2026
LifeSci Corporate Access Event 2026 (San Francisco, Etats-Unis) - transgene
target
Compatibilità
help
Salva
(0)
bookmark_border
upload
Condividi
Skip to content
About us
About us
Executive commitee
Board of Directors
Scientific advisors
Corporate governance
ESG
myvac
myvac – individualized therapeutic vaccines
Pipeline
Pipeline
TG4050
BT-001
TG6050
Publications and Presentations
Clinical trials FAQ
Investors
Investor Presentation & Contacts
Press releases, events & calendar
Financial Information
Stock Information
Annual General Meeting
Career
PHP
Toggle Menu
About us
About us
Executive commitee
Board of Directors
Scientific advisors
Corporate governance
ESG
myvac
myvac – individualized therapeutic vaccines
Pipeline
Pipeline
TG4050
BT-001
TG6050
Publications and Presentations
Clinical trials FAQ
Investors
Investor Presentation & Contacts
Press releases, events & calendar
Financial Information
Stock Information
Annual General Meeting
Career
Menu
Musica
Spettacoli
Difesa / Forze Armate
Fonte:
https://www.transgene.fr/lifesci-corporate-access-event-2026-san-francisco-etats-unis/
Recapiti
alcyon
Comunicati correlati
Diffondi
check
Risparmia tempo nel tuo lavoro
check
Aumenta le possibilità di diffusione
check
Conosci i giornalisti più accreditati
add
Crea il tuo comunicato
Trova
check
Personalizza il tuo digest
check
Salva e organizza i comunicati
check
30.000 Aziende e addetti stampa
add
Apri il tuo profilo
calendar_today
09/01/2026
upload
Musica
Spettacoli
Difesa / Forze Armate
Transgene Publishes Phase I Data Supporting TG4050’s Potential in Preventing Head and Neck Cancer Relapse - transgene
Fonte
TRANSGÈNE
target
Scopri affinità
bookmark_border
0
calendar_today
17/12/2025
upload
Musica
Spettacoli
Difesa / Forze Armate
Transgene – L'immunothérapie contre les cancers
Fonte
TRANSGÈNE
target
Scopri affinità
bookmark_border
0
calendar_today
14/11/2025
upload
Serie/film/TV
Spettacoli
Difesa / Forze Armate
Transgene – L'immunothérapie contre les cancers
Fonte
TRANSGÈNE
target
Scopri affinità
bookmark_border
0
Aggiungi ai preferiti